Your session is about to expire
← Back to Search
Acute Intermittent Hypoxia for Healthy Brain Blood Flow
N/A
Recruiting
Led By Molly G Bright, DPhil
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights
Study Summary
This trial looks at whether short, regular exposures to low oxygen can improve blood flow in the brains of healthy adults.
Who is the study for?
This trial is for healthy English-speaking adults aged 21-50 with no neurological, respiratory, or vascular conditions. Participants must be safe for MRI scans and not have allergies to Tegaderm. Smokers, pregnant women, those with metal implants like pacemakers or severe claustrophobia are excluded.Check my eligibility
What is being tested?
The study is testing whether exposing healthy adults to Acute Intermittent Hypoxia (low oxygen levels at intervals) over three weeks can improve brain blood flow. It compares this method against a sham procedure using magnetic resonance imaging (MRI).See study design
What are the potential side effects?
Potential side effects may include headaches, dizziness, light-headedness or heart palpitations during the hypoxia exposure. However, individuals experiencing these symptoms on the day of the study will be excluded.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Resting cerebral blood flow
Secondary outcome measures
Cerebrovascular reactivity
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: Intermittent HypoxiaActive Control1 Intervention
Participant will visit our center 2-4 times per week for three weeks to receive Acute Intermittent Hypoxia.
Group II: Sham Intermittent HypoxiaPlacebo Group1 Intervention
Participants will visit our center 2-4 times per week for three weeks to receive Sham Intermittent Hypoxia.
Find a Location
Who is running the clinical trial?
Northwestern UniversityLead Sponsor
1,586 Previous Clinical Trials
916,941 Total Patients Enrolled
Molly G Bright, DPhilPrincipal InvestigatorNorthwestern University
1 Previous Clinical Trials
43 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You don't have any known problems with your brain, lungs, or blood vessels.You are able to undergo an MRI scan without any safety concerns.You are allergic to Tegaderm.You have experienced headaches, dizziness, lightheadedness, or heart palpitations on the day of the study.You have sleep apnea, emphysema, or other breathing problems.You have a strong fear of enclosed spaces (like small rooms or tunnels).You smoke a lot.You have known conditions affecting your brain or blood vessels.
Research Study Groups:
This trial has the following groups:- Group 1: Intermittent Hypoxia
- Group 2: Sham Intermittent Hypoxia
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are new participants still eligible to enroll in this research project?
"Affirmative. The clinicaltrials.gov webpage affirms that this study is currently recruiting participants, first posted on May 3rd 2022 and last updated on October 10th 2022. This trial requires 23 patients from a single site."
Answered by AI
Is the age restriction for this experiment limited to individuals younger than 25?
"This medical study has been restricted to patients aged between 21 and 50. There are 37 trials for individuals younger than 18 years old, as well as 103 trails available for those over 65."
Answered by AI
How many participants are eligible for inclusion in this clinical investigation?
"Confirmed. According to information on clinicaltrials.gov, the trial posted on May 3rd 2022 is still open for enrollment and searching for 23 patients from a single site location."
Answered by AI
Am I able to partake in this examination?
"To qualify for this clinical trial, applicants must have a brain disorder and be between 21 to 50 years old. This research endeavour is currently looking for 23 participants."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger